Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jamal Abu Samra
AddedMar 31, 2024
UpdatedMay 31, 2026
Jamal Abu Samra

Jamal Abu Samra

CEO, OnEx Medical

CrunchbaseLinkedIn

Jamal Abu Samra's Career

OnEx Medical
OnEx Medical

Abu Dhabi, Emirate of Abu Dhabi, AE

CEO· C-Suite · Management
Aumet
Aumet

Mountain View, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jamal Abu Samra's Career

OnEx Medical
OnEx Medical
Pre-Seed$1.2M202021Abu Dhabi, Emirate of Abu Dhabi, AE
CEO· C-Suite · Management
Aumet
Aumet
Seed$7.9M1492016Mountain View, CA, US
Co-Founder

Leadership at Aumet

Yahya AqelYahya AqelCo-Founder
Ashraf SamhouriAshraf SamhouriCo-Founder
Tariq KhaderTariq KhaderCo-Founder
Mohammad IssaMohammad IssaCo-Founder
Mohamed BatterjeeMohamed BatterjeeCo-Founder

Similar to Aumet

OnEx MedicalOnEx MedicalAbu Dhabi, Emirate of Abu Dhabi, AESales Platformest. 2021OnEx MedicalAbu Dhabi, Emirate of Abu Dhabi, AE · est. 2021

Onex: A smart sales platform for SMEs in healthcare manufacturing, leveraging AI and market insights for global expansion.

Pre-Seed · $1.2M20
Remedial HealthRemedial HealthNewark, DE, USHealthcare, Pharmaceuticalsest. 2021Remedial HealthNewark, DE, US · est. 2021

Digital B2B platform for authentic, affordable meds in Africa.

Series A · $17.4M38
Healthcare MarketMakerHealthcare MarketMakerNashville, TN, USMarketplace, Softwareest. 2013Healthcare MarketMakerNashville, TN, US · est. 2013

Healthcare MarketMaker: A Nashville-based virtual marketplace for medical/dental practices and equipment.

Angel · $80k5
AZmedAZmedParis, Paris, FRAI Solutions, Healthcareest. 2018AZmedParis, Paris, FR · est. 2018

AZmed: AI-powered solutions optimizing healthcare specialists' workflow.

Seed · $4.3M47

Jamal Abu Samra's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailBrian KimBrian KimCo-Founder · KakaoKim Beom-sooKim Beom-sooCo-Founder · Kakao

People Similar to Jamal Abu Samra

Bobby Le BlancBobby Le BlancCEO · OnexTakeshi TsurutaTakeshi TsurutaBoard Member · OnexTom WestTom WestCo-Founder · LokuJacklyn RomeJacklyn RomeCo-Founder & CEO · OnwardEric ElfmanEric ElfmanCo-Founder · OnitShefali AgarwalShefali AgarwalBoard Member · Gritstone bio